BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36299805)

  • 21. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism and cancer.
    Baron JA; Gridley G; Weiderpass E; Nyrén O; Linet M
    Lancet; 1998 Apr; 351(9109):1077-80. PubMed ID: 9660575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study.
    Uchiyama S; Goto S; Origasa H; Uemura N; Sugano K; Hiraishi H; Shimada K; Okada Y; Ikeda Y;
    Heart Vessels; 2020 Feb; 35(2):170-176. PubMed ID: 31446462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective Cohort Analysis of Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling Central Venous Catheter.
    King R; Schaefer J; Sahai V; Griffith KA; Sood SL
    TH Open; 2022 Jul; 6(3):e221-e229. PubMed ID: 36046199
    [No Abstract]   [Full Text] [Related]  

  • 25. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of lower gastrointestinal bleeding and colorectal neoplasms following initiation of low-dose aspirin: a Danish population-based cohort study.
    Troelsen FS; Farkas DK; Erichsen R; Sørensen HT
    BMJ Open Gastroenterol; 2020 Jul; 7(1):. PubMed ID: 32719046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
    Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
    Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
    Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study.
    Jørgensen H; Horváth-Puhó E; Laugesen K; Brækkan S; Hansen JB; Sørensen HT
    PLoS Med; 2021 Aug; 18(8):e1003770. PubMed ID: 34464405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thirty Days of Aspirin for Venous Thromboembolism Prophylaxis Is Adequate Following Total Knee Arthroplasty, Regardless of the Dose Used.
    Shohat N; Ludwick L; Goel R; Ledesma J; Streicher S; Parvizi J
    J Arthroplasty; 2021 Sep; 36(9):3300-3304. PubMed ID: 34052098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Regular Use of Low-Dose Aspirin and Neovascular Age-Related Macular Degeneration: National Sample Cohort 2010-2015.
    Rim TH; Yoo TK; Kwak J; Lee JS; Kim SH; Kim DW; Kim SS
    Ophthalmology; 2019 Feb; 126(2):274-282. PubMed ID: 30240791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial cancer does not increase the 30-day risk of venous thromboembolism following hysterectomy compared to benign disease. A Danish National Cohort Study.
    Kahr HS; Christiansen OB; Høgdall C; Grove A; Mortensen RN; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
    Gynecol Oncol; 2019 Oct; 155(1):112-118. PubMed ID: 31378374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty.
    Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
    J Arthroplasty; 2018 Jul; 33(7S):S131-S135. PubMed ID: 29656974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin and recurrent venous thromboembolism.
    Prandoni P; Noventa F; Milan M
    Phlebology; 2013 Mar; 28 Suppl 1():99-104. PubMed ID: 23482543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study.
    Søgaard M; Nielsen PB; Skjøth F; Kjaeldgaard JN; Larsen TB
    Cancer Med; 2019 Mar; 8(3):1044-1053. PubMed ID: 30767432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity.
    Pedersen AB; Ehrenstein V; Szépligeti SK; Sørensen HT
    Osteoporos Int; 2017 Dec; 28(12):3421-3430. PubMed ID: 28871320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.